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Abstract: 
Mitotic progression of mammalian cells is tightly regulated by the E3 ubiquitin ligase 
APC/C. Deregulation of APC/C is frequently observed in cancer cells and is suggested to 
contribute to chromosome instability and cancer predisposition. Here, we identified Daxx 
as a novel APC/C inhibitor frequently overexpressed in prostate cancer. Daxx interacts 
with the APC/C coactivator Cdc20 and Cdh1 in vivo, with the binding of Cdc20 dependent 
on the consensus destruction boxes near the N-terminal of the Daxx protein. Ectopic 
expression of Daxx, but not the D-box deleted mutant (Daxx∆D-box), inhibited the 
degradation of APC/Cdc20 and APC/Cdh1 substrates, leading to a transient delay in 
mitotic progression. Daxx is frequently upregulated in prostate cancer tissues; the 
expression level positively correlated with the Gleason score and disease metastasis 
(p=0.027 and 0.032, respectively). Furthermore, ectopic expression of Daxx in a 
non-malignant prostate epithelial cell line induced polyploidy under mitotic stress. Our data 
suggest that Daxx may function as a novel APC/C inhibitor, which promotes chromosome 
instability during prostate cancer development.  
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Introduction: 
Duplicated chromosomes are attached to the mitotic spindles before segregating into 
two copies; this process is under tight control by a protein complex called anaphase 
promoting complex (APC)[1]. APC is an E3-ligase responsible for catalyzing the 
ubiquitination and eventual degradation of mitotic regulatory proteins, such as cyclin B1 
and Securin [1]. Once all the chromosomes are properly aligned and attached to the mitotic 
spindles, APC is activated by the coactivator Cdc20, which complexes with APC and 
functions as an adaptor for substrate recognition [1]. This will result in subsequent 
degradation of APC target proteins and initiation of chromosome segregation [1]. 
APC/Cdc20 is tightly regulated by the mitotic checkpoint proteins, i.e., Mad2 or BubR1, 
which bind to Cdc20 and inhibit APC from targeting its substrates [2]. This inhibition of 
APC/Cdc20 activity ensures that cells will not enter anaphase with unattached 
chromosomes and, as a result, prevents chromosome missegregation [3]. Accordingly, 
aberrant expression of mitotic checkpoint proteins has been found to induce chromosome 
instability and promote cancer development [3]. 
During the late stage of mitosis, APC is activated by Cdh1, another coactivator that 
facilitates the onset of cytokinesis and mitotic exit by targeting a series of APC substrates 
[1]. Similar to APC/Cdc20, deregulation of APC/Cdh1 also plays an important role in 
chromosome instability and possibly attributes to cancer predisposition. Whereas complete 
knockout of Cdh1 caused embryonic lethality in vivo, Cdh1 heterozygous mice are prone to 
spontaneous tumor development [4]. More interestingly, a number of APC/Cdh1 inhibitors 
have been demonstrated to induce chromosome instability in vitro. For example, Id-1, an 
oncoprotein involved in the carcinogenesis of prostate cancer, was shown to suppress 
APC/Cdh1 activity by disrupting the interaction between Cdh1 and APC [5]. 
Overexpression of Id-1 in human prostate epithelial cells induces polyploidy in the 
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presence of the microtubule disrupting agents [5]. Meanwhile, overexpression of Cyclin E, 
an activator of Cyclin dependent kinase 2, has also been shown to inhibit APC/Cdh1
 
and 
result in polyploidy [6].  
Daxx is a transcription repressor mainly localized in the PML-nuclear body within the 
nucleus [7]. Previous study demonstrated that Daxx is associated with the 
chromatin-remodeling complex during S-phase and may play a role in the reassembling of 
the heterochromatin at mitotic entry [8,9]. Meanwhile, Daxx was found to bind to 
kinetochore-associated protein CENP-C [10], which is required for the 
kinetochore-localization of mitotic checkpoint proteins during mitosis [11]. Knockout of 
Daxx has been found to increase the percentage of double-nuclei cells [12]. Furthermore, 
Daxx depletion has been shown to promote the survival of breast cancer cells upon 
treatment with a microtubule stabilization agent [13], an effect that is similar to the 
silencing of mitotic checkpoint protein Mad2 [14]. These findings suggest that Daxx may 
be involved in the regulation of mitotic progression.  
Here, we show that Daxx functions as a novel inhibitor of APC. Daxx binds to APC 
coactivators Cdc20 and Cdh1 and inhibits the degradation of APC substrates during mitosis. 
Daxx level is frequently upregulated in prostate cancer cells and ectopic expression of it 
leads to chromosome missegregation in the non-malignant prostate epithelial cells. Our 
results suggest that Daxx may be involved in the regulation of mitotic progression by 
functioning as a novel APC inhibitor, and Daxx upregulation may be associated with 
prostate cancer development. 
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Results 
Effect of Daxx knockdown on mitotic progression.  
To study the function of Daxx during mitosis, U2OS cells were transiently transfected 
with Daxx siRNA and then synchronized in mitosis by nocodazole treatment. As shown in 
Figure 1A, mitotic progression was similar between the scrambled and Daxx siRNA 
transfected U2OS cells, except at 60 min post-nocodazole treatment, where a transient but 
significant increase in the G1 population was detected in Daxx siRNA transfectants. This 
indicated that knockdown of Daxx resulted in a transient acceleration of mitotic 
progression. Interestingly, the cyclin B1 level was found to be much lower in Daxx siRNA 
transfectants when compared to the control (Figure 1B). One possible explanation for this 
observation would be that APC/Cdc20 is more active when Daxx has been knocked down. 
To test this hypothesis, we first examined if Daxx interacts with Cdc20. As shown in 
Figure 2A, immunoprecipitation of Flag-Daxx protein, using anti-Flag antibody, 
successfully pulled down HA-Cdc20 proteins, indicating that they physically interact with 
each other. The experiment was repeated, using anti-HA antibody, which confirmed the 
interaction between the two proteins (data not shown).  
To investigate if Daxx and Cdc20 colocalize during cell cycle progression, HeLa cells 
were cotransfected with plasmids expressing the DsRed-Daxx and pCS2-GFP-Cdc20. 
Images of cells during S-phase, mitosis and the G1 phase were taken with fluorescence 
microscope. As shown in Supple Figure 1A, Daxx was found to colocalize with Cdc20 
during S-phase and mitosis. Similar to previous reports, Daxx was found to localize into 
several small, round-shaped structures within the nucleus at G1 phase (Supple Figure 1B), 
where these structures are likely to constitute the PML nuclear body [15]. In contrast, 
Cdc20 was undetectable at G1 phase (Supple Figure 1A), possibly due to protein 
degradation mediated by APC/Cdh1 [1]. 
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To identify the Cdc20-binding domain within the Daxx protein, we subsequently 
mutated the two KEN boxes in the Daxx protein (Supple Figure 1B) and repeated the 
experiment using these Daxx mutants. As shown in Figure 2B, the interaction between 
Daxx and Cdc20 was not affected by mutation at one or both KEN boxes. Meanwhile, 
Daxx mutants with deletion at these two KEN boxes can still bind to Cdc20 (Figure 2C, 
lane 4, 6 and 7), suggesting that the two KEN boxes are dispensable for the interaction. 
However, mutation or deletion of the D-boxes sequence was found to completely abolish 
the interaction between the two proteins (Figure 2B, bottom panel and 2C, lane 5 and 8), 
indicating that Daxx binds to Cdc20 through the D-box sequences. 
 
Daxx inhibits APC/Cdc20
 
activity. 
Because Daxx was found to interact with Cdc20 and downregulation of Daxx was 
shown to promote mitotic progression, it is possible that Daxx may function as a novel 
APC/Cdc20
 
inhibitor. To test this idea, cells were transfected with a plasmid expressing a 
fusion protein containing the D-box sequence of cyclin B1 conjugated to luciferase. This 
allowed us to indirectly determine APC/Cdc20 activity by measuring luciferase activity. As 
shown in Figure 3A, luciferase activity was significantly upregulated (~3 fold) in cells 
transfected with the Daxx expression vector, suggesting that Daxx may inhibit APC/Cdc20 
activity, which leads to stabilization of the D-box-conjugated luciferase protein. Meanwhile, 
deletion of the D-box sequences, which abolished the interaction between Daxx and Cdc20, 
was found to alter the inhibitory effect of Daxx on APC/Cdc20 activity (Figure 3A). This 
indicates that the binding of Daxx to Cdc20 is critical for regulating APC/Cdc20 function.  
Mitotic checkpoint proteins, such as Mad2, inhibited APC/Cdc20 activity by 
suppressing both the assembly of APC/Cdc20 and its substrate binding [16]. To study the 
mechanism responsible for the inhibition of APC/Cdc20 by Daxx, we first investigated the 
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effect of Daxx knockdown on APC/Cdc20 assembly. APC/Cdc20 complex formation was 
examined in HeLa cells at mitosis by immunoprecipitating with an anti-Cdc20 antibody. 
As shown in Figure 3B (upper panel), the interaction between Cdc20 and Cdc27, one of the 
components of the APC, was not affected by knockdown of Daxx. Instead, the binding of 
the two substrates, cyclin B1 and Securin, to Cdc20 was significantly increased by 
knockdown of Daxx (Figure 3B, lower panel), indicating that Daxx interfered with the 
substrate binding ability of Cdc20. Interestingly, Daxx was found to also interact with two 
mitotic checkpoint proteins, BubR1 and Mad2 (Figure 3C). Meanwhile, we found that 
knockdown of Daxx decreased the binding of Cdc20 to BubR1 but not to Mad2 (Figure 
3D). These findings further support the idea that Daxx may function as a novel APC/Cdc20 
inhibitor, possibly through facilitating the binding between BubR1 and Cdc20. 
 
Effect of Daxx overexpression on mitotic progression.  
 To further confirm the role of Daxx on mitotic progression, we also investigated the 
consequences of Daxx overexpression. As shown in Figure 4A, mitotic progression of 
HeLa cells was delayed by ectopic expression of Daxx. In addition, cyclin B1 and Securin 
levels were also increased by Daxx expression (Figure 4B), confirming that Daxx delayed 
mitotic progression through the inhibition of APC/Cdc20-mediated cyclin B1 and Securin 
degradation. Strikingly, in Daxx transfectants, levels of Aurora A and Plk1 were also found 
to be upregulated when compared to the vector control (Figure 4B), suggesting that Daxx 
also regulates APC/Cdh1 activity during mitosis. Meanwhile, coimmunoprecipitation assay 
confirmed that Daxx binds to Cdh1, although this interaction does not depends on the 
D-box sequences (Figure 5A & B).  
To determine whether the binding of Daxx to Cdh1 is essential for regulating the 
activity of APC/Cdh1, we repeated the experiment in Figure 4, using the Daxx mutant that 
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does not bind to Cdh1 (Daxx ∆1-344). In agreement with the results in Figure 3, ectopic 
expression of Daxx ∆1-344 did not affect the level of cyclin B1 and Securin (Figure 5C). 
Furthermore, Daxx ∆1-344 also failed to affect the level of Aurora-A and Plk-1 (Figure 
5C), suggesting that disruption of the interaction between Daxx and Cdh1 abolished the 
inhibitory effect of Daxx on APC/Cdh1.  
 
Daxx is overexpressed in prostate cancer  
Aberrant expression of APC inhibitors is frequently found in cancer cells and is 
believed to contribute to chromosome instability observed during cancer development 
[17,18]. To test if Daxx also plays a role in prostate cancer development, we first compared 
the level of Daxx protein in five prostate cancer cell lines and a non-tumorigenic prostate 
epithelial cell line. As shown in Figure 6A, Daxx was detectable in all the cell lines but the 
level was significantly elevated in all the cancer cell line when compared to the 
non-tumorigenic prostate epithelial cells (HPr-1), suggesting that Daxx overexpression may 
be associated with malignant transformation of prostate epithelial cells. We then examined 
the level of Daxx expression in prostate tissues from normal donors, patients with BPH or 
PIN, or from prostate cancer patients at primary or advanced stage. Figure 6B shows the 
representative results of the Daxx immunohistochemistry staining. In agreement with 
previous studies, positive Daxx staining was found to localize mainly within the nucleus of 
the cells (Fig 6B, right panel). Analysis of the staining intensity for all the specimens 
revealed that Daxx was expressed at low or undetectable levels only in the normal prostate 
tissues (Figure 6C). However, more than 90% of the prostate cancer tissues (49 in 55) were 
found to express moderate to high levels of Daxx protein, suggesting that Daxx is 
frequently overexpressed in prostate cancer cells (Figure 6C). Meanwhile, the level of 
Daxx expression was also found to be significantly correlated with both the tumor stage 
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(P>0.027, Figure 6C) and disease metastasis (P>0.032, Figure 6D). These results further 
support the idea that Daxx may play roles in both the development and the progression of 
prostate cancer. 
 
Daxx overexpression induced chromosome instability in prostate epithelial cells 
To investigate the role of Daxx in prostate cancer development, we ectopically 
expressed Daxx in the non-malignant prostate epithelial cell line (HPr-1) (Figure 7A). Flow 
cytometry analysis revealed that the percentage of cells at G1 phase was decreased in Daxx 
transfectants when compared to the empty vector control, which is consistent with the 
results observed in Daxx silencing (Figure 1A). Although in unsynchronized cells, Daxx 
overexpression did not affect the level of Aurora-A or Plk-1 (Fig 7A). In cells 
synchronized using nocodazole, upregulation of Plk-1 was found in both Daxx 
transfectants (Figure 7B), confirming that Daxx can stabilize Plk-1 in HPr-1 cells. However, 
we were unable to detect any difference in Aurora-A protein level between the control and 
Daxx transfectants even after synchronization. More importantly, 48 hours after 
nocodazole treatment, Daxx transfectants, but not the empty vector control, showed a 
significant increase in cells containing DNA content greater than 4N (Figure 7C). In 
agreement, metaphase analysis revealed that the percentage of cell having abnormal 
chromosome number was also increased in cells overexpressing Daxx (Figure 7D). Taken 
together, these results suggest that ectopic Daxx expression can promote chromosome 
instability, possibly through aberrant inhibition of APC/Cdh1 during mitosis.     
 
Discussion  
Precise control of APC activity is crucial for maintaining the genomic integrity in 
mammalian cells, and deregulation of APC is frequently associated with chromosome 
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instability and cancer predisposition [19]. Here, we identified Daxx as a novel APC 
inhibitor frequently upregulated in prostate cancer. 
Previous study revealed that knockout of Daxx leads to abnormal cytokinesis [12], 
although whether it plays a key role in mitotic progression is largely unknown. Our data 
suggest that Daxx not only physically binds to the Cdc20 and Cdh1, but also regulates their 
activities during mitotic progression. Cdc20 and Cdh1 are known to bind specifically to a 
consensus sequences such as D or Ken boxes, which are highly conserved among its 
substrates and regulators. This is also true for the Daxx protein, which contains four D-box 
and 3 KEN box sequences. Surprisingly, only the D-boxes are crucial for mediating the 
interaction with Cdc20, while the Cdh1-interacting domain may lies within the amino acid 
160-334. Recently, Daxx was found to interact with RASSF1A, which was found to be an 
APC/Cdc20 inhibitor and substrate, with the binding domain being located at residues 
290-740 [20]. It is thus possible that Daxx may be part of an APC inhibitory complex.     
Our finding that Daxx interacts with Mad2 and BubR1 and inhibits APC/Cdc20 
activity suggests that it likely plays a role in mitotic checkpoints. This is supported by the 
finding that Daxx depletion promotes the survival of breast cancer cells following 
treatment with microtubule stabilization agents [13], an effect which is similar to the 
silencing of mitotic checkpoint protein Mad2 [14]. Meanwhile, Daxx has been identified as 
a direct binding partner of the kinetochore-associated protein CENP-C [10], which is 
required for the kinetochore-localization of mitotic checkpoint proteins during mitosis [11]. 
More interestingly, truncation of the CENP-C binding region was found to abolish the 
inhibitory effect of Daxx on APC/Cdc20 (data not shown). Since we found that knockdown 
of Daxx reduce the interaction between Cdc20 and BubR1, it is reasonable to speculate that 
Daxx delays mitotic progression by promoting the assembly of the mitotic checkpoint 
complex.  
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Giovinazzi et al recently demonstrated that addition of Daxx protein in vitro does not 
induce the activation of the APC/C [20]. Meanwhile, they reported that knockdown of 
Daxx suppresses cyclinB1 protein level in mitotic cells and as a result accelerates mitotic 
progression [20]. It is not clear if the use of different cell line (U2OS and Hela in the 
current study and HEp2, a Hela-contaminated human epidermoid cancer cells in their study) 
may account for the discrepancy. Nevertheless, it would be worth to test whether Daxx 
overexpression on their system indeed produces an effect opposite to that by the 
shRNA-mediated Daxx knockdown.  
An important question that needs to be addressed is how Daxx’s function is regulated 
during the cell cycle. Unlike another APC/Cdc20 inhibitor, EMI1, which oscillates 
drastically during the cell cycle [21], the level of Daxx protein changed only slightly 
between different time courses (data not shown). However, Daxx protein has been shown 
to undergo a cell cycle-dependent translocation in previous studies [8,15]. During late 
S-phase, Daxx is released from PML to the heterochromatin, which then moves back to 
PML when the cell reached G2 phase [8]. It leaves PML again at the entry of mitosis and 
does not relocate into the PML until the G1 phase [15]. This pattern of cell cycle 
translocation seems to fit well with its inhibitory function on APC/Cdc20.  
Unlike APC/Cdc20, which is known to be regulated by the mitotic checkpoint, how 
APC/Cdh1 is regulated during late mitosis is still largely unknown. An in vitro study by 
Pfleger’s group revealed that Mad2b inhibits the activity of APC/Cdh1 by blocking the 
release of substrates from the APC/Cdh1 complex [22]. Meanwhile, Id-1, an oncoprotein 
involved in multiple signaling pathways in tumorigenesis [23], was also found to to protect 
Aurora-A and Cdc20 proteins from APC/Cdh1 mediated degradation. Similar to Mad2b 
and Id-1, overexpression of Daxx also stabilized these APC/Cdh1
 
substrates, indicating that 
Daxx may also function as a potential inhibitor of APC/Cdh1.
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Many of the APC/Cdh1 inhibitors have been found to be overexpressed in cancer cells. 
These include EMI1 (multiple cancers) [17], Mad2b (colon cancer) [24] and Id-1 (multiple 
cancers) [23]. This is also true for Daxx, which we found to be upregulated in all the 
prostate cancer cell lines that we tested. Meanwhile, the expression of Daxx in prostate 
cancer tissue specimens was found to correlate with both tumor stage and disease 
metastasis, suggesting a positive role for Daxx in the development and progression of 
prostate cancer. Interestingly, as shown in HPr-1 cells, upregulation of Daxx alone is not 
sufficient for inducing chromosome instability. However, exposure of the Daxx 
transfectants to nocodazole was found to induce chromosome instability (Figure 7), which 
was accompanied by upregulation of the APC/Cdh1 substrate Plk1. Degradation of Plk-1 is 
crucial for mitotic exit and aberrant expression of Plk1 was reported to induce cytokinesis 
failure and chromosome instability [25,26], supporting that stabilization of Plk-1 by Daxx 
may contribute to chromosome instability and prostate carcinogenesis. 
In conclusion, our results suggest for the first time that Daxx may function as a novel 
inhibitor of APC/Cdc20 and APC/Cdh1. Overexpression of Daxx, which was shown to 
affect mitotic checkpoint function and chromosome stability, is frequently detected in 
prostate cancer tissues and may contribute to prostate cancer development. 
 
Materials and method: 
Cell line and cell culture condition Three Human Prostate cancer cell lines LNCaP, PC-3 
and DU145, the cervical cancer cell line HeLa, and the HEK293FT cells were obtained 
from American Type Culture Collection (Rockville, MD). C42b and 22RV1 were gifts 
from Professor Franky Chan (Department of Anatomy, Chinese University of Hong Kong). 
The osteosarcoma cancer cell line U2OS was a gift from Dr Y.P. Ching (Department of 
Anatomy, University of Hong Kong). The immortalized prostate epithelial cell line HPr-1 
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was established in our previous study [27]. All the prostate cancer cell lines were 
maintained in RPMI 1640 (Invitrogen, Carlsbad, CA) supplemented with 5% fetal bovine 
serum and penicillin/streptomycin. HEK293. HeLa and U2OS cells were maintained in 
DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum and 
penicillin/streptomycin. The immortalized prostate epithelial cell line HPr-1 was 
maintained in Keratinocytes-SFM (Invitrogen, Carlsbad, CA) and penicillin/streptomycin. 
All cells were kept at 37
o
C in 5% CO2. 
Cell synchronization was carried out using nocodazole block. Briefly, cells were first 
treated with 330 nM of nocodazole for 16 hr. The rounded-up cells were harvested by 
shake-off and placed into fresh medium. The cells were then collected at different time 
points for western blotting or flow cytometry analysis. 
 
Plasmids and transient transfection The pFlag-Daxx was obtained from Professor 
Horikoshi (Mallinckrodt Institute of Radiology, Washington University School of 
Medicine). The Daxx truncated mutants were generated by amplifying the Daxx fragment, 
which were then cloned into the pFlag empty vector. The plasmids expressing the Daxx 
point mutants were generated using the site-directed mutagenesis kit (Stratagene, La Jolla, 
CA), according to the manufacturer’s instructions. pDsRed-Daxx was generated by cloning 
the full-length Daxx cDNA into the pDsRed empty vector. The pSC2-HA-Cdh1 and 
pSC2-HA-Cdc20 was provided by Professor Kirschner (Department of Cell Biology, 
Harvard Medical School) through Addgene (Cambridge, MA). The pCS2-GFP-cdc20 
plasmid was a gift from Professor Salmon (Department of Biology, University of North 
Carolina). All plasmids were transiently transfected into the cells, using the Fugene 6 
reagent (Roche, Indianapolis, IN) following the protocol provided by the manufacturer. 
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Generation of stable Daxx transfectants To generate stable transfectants overexpressing 
Daxx protein, full length Daxx cDNA was first cloned into the pLenti6-V5-Topo vector 
(Invitrogen, Carlsbad, CA). The resulting plasmid was transfected into 293HT cells, and 
the Lentivirus was used to infect the HPr-1 cells. Stable clones were selected using 6.5 
µg/ml of blasticidine. 
 
Site-directed mutagenesis Daxx D-boxes mutant were generated by site-directed 
mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the manufacturer’s 
instruction. One hundred nanogram of wild type pFlag-Daxx was used as template and 100 
ng of each primer (Daxx D-box mutant 1: 5’ GCTGCCGGACACAGCATTGGCCTC-3’; 
Daxx D-box mutant 2: 5’-CTCCCCGGACAGCAGATCCAGCTCATG-3’; Daxx D-box 
mutant 3: 5’-CAGGAGGGACGTCACATCGATCTCATC-3’; Daxx D-box mutant 4: 
5’-AAGAGAGGAGCTCGGATCCAAGGCACC-3’) were used for the 4 putative D-boxes 
mutation in the D-box region. The sequence of pFlag-Daxx D-boxes mutant was confirmed 
by DNA sequencing using 5’-aggttaacaggcgcattgag-3’ and 5’- actagggccctcaccagaat-3’ for 
5’ and 3’end respectively. 
 
Small interference RNA si-RNA targeting Daxx, 5’-GGAGTTGGATCTCTCAGAAT -3’, 
and scramble RNA oligo were purchased from Dharmacon (Chicago, IL). Cells were 
seeded on a T25 flask at a confluency of 50% one day before transfection. si-RNA was 
transfected into the cells using Lipofectamine
TM
 2000 (Invitrogen, Carlsbad, CA), 
following the manufacturer’s instructions. 
  
Analysis of APC/Cdc20
 
activity The pGL3-D-box-Luc plasmid was a gift from Dr. Jin 
(Department of Biochemistry, The University of Hong Kong). It was constructed by 
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inserting the DNA fragment encoding the N-terminus (1-119 a.a.) of the human cyclin B 
protein into the pGL3-control vector. The resulting plasmid encodes a luciferase protein 
that was conjugated with the N-terminus (containing the D-box) of the cyclin B protein. 
Luciferase activities (Firefly) were measured, using the Dual Luciferase reporter assay kit 
(Promega, Madison, WI) and normalized with the internal control (Renilla). Each 
experiment was repeated in triplicate, and each data point represents a mean and SD. 
Statistical difference was determined by Student’s t-test and was considered significant at p 
< 0.05. 
 
Western blotting Experiments were carried out as previously described [28]. Briefly, 
whole-cell lysate was prepared by resuspending the cell pellet in RIPA buffer (50 mM 
Tris–HCl
 
pH 8.0, 150 mM NaCl, 1% NP40, 0.5% deoxycholic acid, 0.1% SDS), including 
protease inhibitors (1 mM Na3VO4, 1 µg/ml aprotinin, 1 µg/ml leupeptin, and 1 mM 
PMSF), and protein concentrations were measured using DC Protein Assay kit (Bio-Rad, 
Hercules, CA, USA). Protein extract was resolved by electrophoresis and then transferred 
to a PVDF membrane (Amersham, Piscataway, NJ, USA). The membrane was then 
incubated with primary antibodies for 1-2 h at room temperature against Daxx, secruin, 
cyclin B1, Securin, c-myc, Cdc20, Aurora A, BubR1, β-actin (Santa Cruz Biotechnology, 
CA, USA), Plk1 (Zymed, CA, USA), Flag, HA (Sigma, MO, USA), Mad2 and Cdc27 (BD 
Biosciences, CA, USA), respectively. After washing with TBS-T, the membrane was 
incubated with secondary antibody against mouse, rabbit or goat IgG, and the signals were 
visualized using ECL plus western blotting system (Amersham, Piscataway, NJ, USA). 
 
Flow cytometry analysis Cells were fixed with 1 ml ice cold 70% ethanol and stored at 4
o
C. 
After fixation, cell pellets were collected by centrifugation, resuspended with 500 µl PBS, 
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and then incubated at 4
o
C a day before performing flow cytometry. The next day, cells 
were stained with propidium iodide (50 µg/ml)
 
and RNase (1 µg/ml) for 30 min. Cell cycle 
analysis was
 
performed on a flow cytometer EPICS profile analyzer and analyzed
 
using the 
ModFit LT2.0 software (Coulter, Miami, FL). 
 
Metaphase analysis Metaphase cells were obtained by treating HPr-1cells with nocodazole 
at a final concentration of 200 nM for 48 hr. The cells were collected, treated with 0.8% 
sodium citrate for 15 min at 37
o
C, and then fixed in methanol/acetic acid in a ratio of 3:1. 
Cell suspension was dropped onto slides and dried. Chromosome number of at least 50 
metaphase cells was counted under light microscopy with 400 x magnification. Each 
experiment was repeated in triplicate, and each data point represents the mean and SD. 
Statistical difference was determined by Student’s t-test and was considered significant at p 
< 0.05. 
 
Coimmunoprecipitation assay Cells were lys d in RIPA buffer after transfected with 
different constructs. Cell lysate was first precleared with normal mouse IgG and protein G 
agarose for 1 hr. Immunoprecipitation was then performed with agarose-conjugated 
anti-FLAG antibody or with anti-Cdc20 antibody. The mixture was incubated with gentle 
rocking overnight at 4
o
C. The resin was then washed three times with lysis buffer. 
Immunoprecipitate pulled down by anti-Flag antibody was eluted with 3×Flag peptide (150 
ng/ml) for 10 minutes at 4°C. For the immunoprecipitate pulled-down by anti-Cdc20 
(mouse) or anti-Daxx antibody (rabbit), the sample was boiled in 2x sample buffer for ten 
minutes. The eluted complex was loaded onto SDS-polyacrylamide gel for electrophoresis 
and Western blotting analysis with the procedures described above. 
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Live Cell Imaging HeLa cells were seeded onto glass bottom microwell dishes (MatTek 
Corporation, Ashland, MA), followed by transient transfections with the pDsRed-Daxx and 
the GFP-cdc20 plasmids. The transfected cells were synchronized with 2 mM thymidine for 
16 hrs.
 
The cultures were transferred to and maintained at 37°C/5% CO2, with a 
micro-incubator fitted to a microscope stage. Confocal images were taken at defined zoom 
(X40 Plan-neo DIC 1.3 N.A. objective), using a Zeiss Axiovert 200 M microscope with a 
Nipkow disk-based spinning confocal head (Ultraview ERS, Perkin Elmer, MA, USA). 
Pictures were taken every 6 minutes for 20 hours using the Ultraview acquisition software 
(Perkin Elmer, MA, USA). 
 
Immunohistochemistry study on prostate tissue array Immunohistochemistry was carried 
out using the Avidin–Biotin Complex (ABC) Vectastain Kit (Vector Laboratories, 
Burlingame, CA), according to the manufacturer’s instructions. Briefly, tissue microarray 
constructed in previous studies [29] were sectioned, deparaffinized and rehydrated using the 
standard protocol. The sections were then blocked with 0.3% H2O2 in methanol for 20 
minutes followed with normal serum at 37°C for 30 minutes. Sections were then incubated 
with anti-Daxx antibody and then with secondary antibody. Finally, the sections were 
incubated with ABC reagent before stained with diaminobenzidine (DAB) and 
counterstained with Mayer’s hematoxylin. All of the stained sections were evaluated in a 
blinded manner without prior knowledge of the patient data. The intensity of all three cores 
of each sample was scored as low, moderate and high.  
 
Statistical analysis Statistical analysis was performed using SPSS 15.0 software (SPSS Inc., 
Chicago, IL). Differences in Daxx expression among different histological groups of 
specimens were analyzed by the Mann–Whitney test. The correlation of Daxx expression 
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level, with Gleason score or disease metastasis, was analyzed by Spearman’s rank test. Data 
of the APC/Cdh1 assay were analyzed by t-test. For all tests, a P-value < 0.05 was 
considered to be significant. 
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Figures legend: 
Figure 1. Effect of Daxx knockdown on mitotic progression. A. U2OS cells transiently 
transfected with scrambled or Daxx siRNA were synchronized with nocodazole for 16 
hours. Mitotic cells were released in normal medium, collected at different time points, and 
then examined by flow cytometry. B. Levels of Daxx and cyclin B1 at each time point were 
analyzed by Western blotting. Intensity of the gel image was quantified by band 
densitometry (right panel). 
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Figure 2. Daxx interacts with the APC/C coactivator Cdc20. A. Daxx interacts with 
Cdc20. HEK293 cells cotransfected with HA-Cdc20 and Flag-Daxx were lysed and 
immunoprecipitated with anti-Flag antibody. Western blotting with anti-HA antibody 
revealed that Cdc20 was coprecipitated with Daxx. B. The KEN boxes but not the D-boxes 
in Daxx protein are dispensable for interacting with Cdc20. Coimmunoprecipitation was 
performed with the KEN and D-box mutants. Note that the interaction between the KEN 
box mutants and Cdc20 were similar to that of the wild-type (top panel) but the mutation of 
the D-boxes completely abolished the interaction (bottom panel). C. Cdc20-interacting 
domain is located within the N-terminal of the Daxx protein. Coimmunoprecipitation was 
carried out using a series of Daxx truncation mutants (right panel), and the 
immunoprecipitants were analyzed by western blotting (left panel). Note that the mutants 
Daxx (∆300-740) and Daxx (∆1-334) failed to interact with Cdc20 (lane 5 & 8). 
 
Figure 3. Daxx regulates APCCdc20 activities. A. Daxx overexpression inhibited 
APC/Cdc20 activity. To measure the APC/Cdc20 activity, the construct expressing a 
Luciferase protein that is tagged with the D-box of the cyclin B was cotransfected with 
constructs expressing the full length or truncation mutants of Daxx protein. Luciferase 
activity (Firefly) was measured and normalized using the internal control (Renilla). 
Overexpression of Daxx, but not the Daxx (∆1-334) that failed to interact with Cdc20, 
resulted in three fold increase of the luciferase activity. B. HeLa cells transfected with 
scrambled or Daxx siRNA were synchronized by double thymidine block, released for 9 
hours, and then lysed for immunoprecipitation against anti-Cdc20 antibody. Note that Daxx 
knockdown increase the binding of Cdc20 with its substrates (lower panel) but did not 
affect the assembly of the APC/Cdc20 complex (upper panel) were upregulated by Daxx 
knockdown. C. Daxx interacts with mitotic checkpoint proteins. Flag-Daxx was 
Page 20 of 30Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
21 
 
cotransfected with either HA-Mad2 or Myc-BubR1 into HEK293 cells. Cells were lysed 
and immunoprecipitated with anti-Flag antibody before analysed with western blot against 
HA and myc antibodies. D. Immunoprecipitates from B. was reanalyzed with Mad2 and 
BubR1 antibodies. Note that binding of Cdc20 and BubR1 was affected by Daxx 
knockdown. 
 
Figure 4. Effect of Daxx overexpression on mitotic progression A. HeLa cells transfected 
with pFlag empty vector or pFlag Daxx vector were synchronized with nocodazole for 16 
Hours. Mitotic cells were released, collected at different time points, and then examined by 
flow cytometry. B. Levels of Daxx, cyclin B1, Securin, Aurora A and Plk-1 at each time 
point were analyzed by western blotting. Intensity of the gel image was quantified by band 
densitometry (right panel) 
  
Figure 5. Daxx binds to and regulates Cdh1 A. Daxx interacted with Cdh1 in vivo. 
HEK293 cells co-transfected with Flag-Daxx and HA-Cdh1 were lysed and 
immunoprecipitated with anti-Flag antibody. Note that Cdh1 was detected in the 
coimmunoprecitate and the mutation of D-boxes does not affect the interaction between 
Daxx and Cdh1 (right Panel). B. The Daxx sequence 161-299 is required to interact with 
Cdh1. Coimmunoprecipitation was conducted with Daxx truncation mutants, and the 
immunoprecipitates were analyzed by western blotting. Note that deletions of the 
sequences at 161-299 completely abolished the interaction with Cdh1. C. Overexpression 
of the Daxx mutant with deletion of the region (1-344 a.a.) does not stabilized, Cycin B1, 
Securin, Aurora-A or Plk-1 proteins. HeLa cells transfected with pFlag empty vector or 
pFlag Daxx mutant vector were synchronized with nocodazole for 16 Hours, released, and 
then collected for western blotting analysis. 
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Figure 6. Daxx is upregulated in prostate cancer A. Daxx expression was examined in 
prostate cell lines. The level of Daxx was upregulated in all prostate cancer cell lines. B. 
Daxx expression in clinical prostate specimens was analyzed by IHC. Strong positive 
(nuclear staining) was found in prostate cancer tissues whereas weak staining was found in 
BPH tissues. C & D. Statistical analysis of the staining intensity of the specimens revealed 
that the expression level of Daxx was correlated with the tumor stage and disease 
metastasis.  
 
Figure 7. Daxx overexpression induces chromosome instability. A. Daxx was ectopically 
expressed in HPr-1. Both the pool and the clone expressed high level of Daxx protein when 
compared to the control. B. Upregulation of Daxx stabilized Plk-1 protein. The HPr-1 cells 
with Daxx transfectants or empty vector were synchronized with nocodazole for 16 hours. 
Mitotic cells were then collected and lysed for western blotting analysis. C & D. Ectopic 
expression of Daxx promoted chromosome instability. Daxx transfectant or the empty 
vector control was treated with nocodazole for 48 hours. C. DNA content was analyzed by 
flow cytometry. Note that cells with DNA content greater than 4N were observed in Daxx 
transfectants but not in the empty vector. D. Chromosomes were analyzed by metaphase 
spread, and the chromosome number was counted under microscope. Note that ectopic 
Daxx expression resulted in an increase in the number of cells with abnormal chromosome 
number (<40 or >50). 
 
 
Page 22 of 30Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
  
 
 
 
270x340mm (72 x 72 DPI)  
 
 
Page 23 of 30 Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
  
 
 
 
259x337mm (72 x 72 DPI)  
 
 
Page 24 of 30Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
  
 
 
 
256x340mm (72 x 72 DPI)  
 
 
Page 25 of 30 Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
  
 
 
 
255x346mm (72 x 72 DPI)  
 
 
Page 26 of 30Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
  
 
 
 
256x340mm (72 x 72 DPI)  
 
 
Page 27 of 30 Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
  
 
 
 
255x340mm (72 x 72 DPI)  
 
 
Page 28 of 30Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
  
 
 
 
255x340mm (72 x 72 DPI)  
 
 
Page 29 of 30 Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
For Peer Review
  
 
 
 
258x348mm (72 x 72 DPI)  
 
 
Page 30 of 30Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 by guest on D
ecem
ber 13, 2012
http://carcin.oxfordjournals.org/
D
ow
nloaded from
 
